Evidence map›Paper›PMID 26100872›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

The histone methyltransferase SETDB1 represses endogenous and exogenous retroviruses in B lymphocytes.

Patrick L Collins, Katherine E Kyle, Takeshi Egawa, Yoichi Shinkai, Eugene M Oltz

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. The Many Faces of SetDB1.Epigenomes · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Histone methyltransferase SETDB1 safeguards mouse fetal hematopoiesis by suppressing activation of cryptic enhancers.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Patrick L CollinsDepartment of Pathology, Washington University School of Medicine, St. Louis, MO 63110;
Katherine E KyleDepartment of Pathology, Washington University School of Medicine, St. Louis, MO 63110;
Takeshi EgawaDepartment of Pathology, Washington University School of Medicine, St. Louis, MO 63110;
Yoichi ShinkaiCellular Memory Laboratory, RIKEN, Saitama 351-0198, Japan.
Eugene M OltzDepartment of Pathology, Washington University School of Medicine, St. Louis, MO 63110; eoltz@wustl.edu.

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTESR37AI118852 · NIAID · OHIO STATE UNIVERSITY · PI Eugene M Oltz · 2021 to 2026
$2.8M
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTESR01AI118852 · NIAID · WASHINGTON UNIVERSITY · PI OLTZ, EUGENE M · 2015 to 2019
$1.9M
GENE REGULATION GOVERNING T LYMPHOCYTE FATE DECISIONSR01AI097244 · NIAID · WASHINGTON UNIVERSITY · PI EGAWA, TAKESHI · 2012 to 2016
$1.9M
Accessibility Control of Antigen Receptor Gene AssemblyR01AI079732 · NIAID · WASHINGTON UNIVERSITY · PI OLTZ, EUGENE M · 2009 to 2013
$1.9M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1TR000448NCI NIH HHS P30 CA091842NCI NIH HHS P30 CA91842NIAID NIH HHS AI 079732NIAID NIH HHS AI 097244NIAID NIH HHS AI118852NIAID NIH HHS R01 AI079732NIAID NIH HHS R01 AI097244NIAID NIH HHS R01 AI118852NIAID NIH HHS R37 AI118852NIAID NIH HHS T32 AI007163NIAID NIH HHS T32 AI 7163-34
6 · The paper itself

Abstract

Genome stability relies on epigenetic mechanisms that enforce repression of endogenous retroviruses (ERVs). Current evidence suggests that distinct chromatin-based mechanisms repress ERVs in cells of embryonic origin (histone methylation dominant) vs. more differentiated cells (DNA methylation dominant). However, the latter aspect of this model has not been tested. Remarkably, and in contrast to the prevailing model, we find that repressive histone methylation catalyzed by the enzyme SETDB1 is critical for suppression of specific ERV families and exogenous retroviruses in committed B-lineage cells from adult mice. The profile of ERV activation in SETDB1-deficient B cells is distinct from that observed in corresponding embryonic tissues, despite the loss of repressive chromatin modifications at all ERVs. We provide evidence that, on loss of SETDB1, ERVs are activated in a lineage-specific manner depending on the set of transcription factors available to target proviral regulatory elements. These findings have important implications for genome stability in somatic cells, as well as the interface between epigenetic repression and viral latency.

Indexed as

AnimalsBlotting, WesternB-LymphocytesBone Marrow CellsCells, CulturedDNA MethylationEndogenous RetrovirusesEpigenesis, GeneticFlow CytometryGene Expression ProfilingHistone-Lysine N-MethyltransferaseHistonesHost-Pathogen InteractionsLysineMethylationMice, Inbred C57BLHistone-Lysine N-MethyltransferaseHistonesLysineSETDB1 protein, mouseepigeneticshistone methylationrepressionretrovirusestransposable elements

Identifiers

PMID26100872
PMCPMC4500218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.